跳至主要内容
临床试验/NCT06820541
NCT06820541尚未招募不适用

Prophylactic Endoscopic Transpapillary Gallbladder Drainage to Prevent Post-ERCP Cholecystitis After Covered Metal Stent Placement for Distal Biliary Obstruction: a Randomized Controlled Study

Azienda Ospedaliera Universitaria Integrata Verona2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
80
试验地点
2
主要终点
Acute cholecystitis

研究概览

简要总结

The goal of this randomized controlled trial is to determine whether primary prophylaxis with transpapillary gallbladder drainage prevents acute cholecystitis after fully-covered self-expandable metal stents placement during endoscopic retrograde cholangiopancreatography for malignant distal biliary obstruction in patients at higher risk of post-endoscopic retrograde cholangiopancreatography acute cholecystitis.

The main question it aims to answer is:

Does prophylactic transpapillary gallbladder drainage reduce the rate of post-endoscopic retrograde cholangiopancreatography acute cholecystitis in high-risk patients? Researchers will compare patients who undergo transpapillary gallbladder drainage to patients without transpapillary gallbladder drainage to see if transpapillary gallbladder drainage reduces the rate of acute cholecystitis.

Participants will:

  1. receive or not transpapillary gallbladder drainage before fully-covered self-expandable metal stents placement
  2. will be followed up at one, three, and six months to ascertain the onset of acute cholecystitis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

盲法说明

Participants will be not informed about the treatment received

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients
  • Signed informed consent
  • Patients requiring covered metal stent placement for managing MBO
  • High-risk of post-endoscopic cholangiopancreatography acute cholecystitis according to the following criteria:
  • tumor involvement of the cystic duct orifice confirmed on magnetic resonance imaging, computed tomography, endoscopic ultrasound, or at endoscopic cholangiopancreatography;
  • presence of at least 2 of the following:
  • gallbladder stones;
  • CBD diameter ≤ 10 mm;
  • intraprocedural gallbladder opacification;
  • cystic duct orifice at risk of being covered by the fully-covered stent

排除标准

  • History of cholecystectomy
  • Endoscopic retrograde cholangiopancreatography not feasible for duodenal stenosis or failed biliary cannulation
  • Patients with previous gallbladder drainage
  • Acute cholecystitis is already present based on the Tokyo guidelines

结局指标

主要结局

Acute cholecystitis

时间窗: 6 months

The rate of acute cholecystitis, defined according to the Tokyo guideline, will be calculated and compared between the two groups

次要结局

  • Overall adverse events(6 months)
  • Hospitalization(6 months)
  • Disease-free survival(6 months)
  • Procedure time(1 month)
  • Technical success(1 mont)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验